Literature DB >> 19443661

RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.

Abdel Kareem Azab1, Feda Azab, Simona Blotta, Costas M Pitsillides, Brian Thompson, Judith M Runnels, Aldo M Roccaro, Hai T Ngo, Molly R Melhem, Antonio Sacco, Xiaoying Jia, Kenneth C Anderson, Charles P Lin, Barrett J Rollins, Irene M Ghobrial.   

Abstract

The interaction of multiple myeloma (MM) cells with the bone marrow (BM) milieu plays a crucial role in MM pathogenesis. Stromal cell-derived factor-1 (SDF1) regulates homing of MM cells to the BM. In this study, we examined the role of RhoA and Rac1 GTPases in SDF1-induced adhesion and chemotaxis of MM. We found that both RhoA and Rac1 play key roles in SDF1-induced adhesion of MM cells to BM stromal cells, whereas RhoA was involved in chemotaxis and motility. Furthermore, both ROCK and Rac1 inhibitors reduced SDF1-induced polymerization of actin and activation of LIMK, SRC, FAK, and cofilin. Moreover, RhoA and Rac1 reduced homing of MM cells to BM niches. In conclusion, we characterized the role of RhoA and Rac1 GTPases in SDF1-induced adhesion, chemotaxis, and homing of MM cells to the BM, providing the framework for targeting RhoA and Rac1 GTPases as novel MM therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443661      PMCID: PMC2713475          DOI: 10.1182/blood-2009-01-199281

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

2.  Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

Authors:  F Sanz-Rodríguez; A Hidalgo; J Teixidó
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

3.  The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma.

Authors:  Teru Hideshima; Dharminder Chauhan; Toshiaki Hayashi; Klaus Podar; Masaharu Akiyama; Deepak Gupta; Paul Richardson; Nikhil Munshi; Kenneth C Anderson
Journal:  Mol Cancer Ther       Date:  2002-05       Impact factor: 6.261

Review 4.  VLA-4-dependent myeloma cell adhesion.

Authors:  F Sanz-Rodríguez; J Teixidó
Journal:  Leuk Lymphoma       Date:  2001-04

5.  The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-08-30       Impact factor: 22.113

6.  CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

Authors:  Jolanta Libura; Justyna Drukala; Marcin Majka; Oana Tomescu; Jean Marc Navenot; Magda Kucia; Leah Marquez; Stephen C Peiper; Frederic G Barr; Anna Janowska-Wieczorek; Mariusz Z Ratajczak
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.

Authors:  Julie Caramel; Frédérique Quignon; Olivier Delattre
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway.

Authors:  Sok-Hyong Lee; Jeannette Kunz; Sue-Hwa Lin; Li-yuan Yu-Lee
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 9.  Mammalian Rho GTPases: new insights into their functions from in vivo studies.

Authors:  Sarah J Heasman; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2008-09       Impact factor: 94.444

10.  Inadequate activation of the GTPase RhoA contributes to the lack of fibronectin matrix assembly in von Hippel-Lindau protein-defective renal cancer cells.

Authors:  Monica Feijóo-Cuaresma; Fernando Méndez; Alfredo Maqueda; Miguel A Esteban; Salvador Naranjo-Suarez; Maria C Castellanos; Mercedes Hernández del Cerro; Silvia N Vazquez; Angeles García-Pardo; Manuel O Landázuri; Maria J Calzada
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

View more
  58 in total

1.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

2.  In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.

Authors:  M Martínez-Moreno; M Leiva; N Aguilera-Montilla; S Sevilla-Movilla; S Isern de Val; N Arellano-Sánchez; N C Gutiérrez; R Maldonado; J Martínez-López; I Buño; J A García-Marco; P Sánchez-Mateos; A Hidalgo; A García-Pardo; J Teixidó
Journal:  Leukemia       Date:  2015-12-10       Impact factor: 11.528

Review 3.  Targeting Rac and Cdc42 GTPases in Cancer.

Authors:  María Del Mar Maldonado; Suranganie Dharmawardhane
Journal:  Cancer Res       Date:  2018-06-01       Impact factor: 12.701

4.  Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Authors:  Amanda P Struckhoff; Jason R Vitko; Manish K Rana; Carter T Davis; Kamau E Foderingham; Chi-Hsin Liu; Lyndsay Vanhoy-Rhodes; Steven Elliot; Yun Zhu; Matt Burow; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

Review 5.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

6.  The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

Authors:  Siobhan V Glavey; Salomon Manier; Alessandro Natoni; Antonio Sacco; Michele Moschetta; Michaela R Reagan; Laura S Murillo; Ilyas Sahin; Ping Wu; Yuji Mishima; Yu Zhang; Wenjing Zhang; Yong Zhang; Gareth Morgan; Lokesh Joshi; Aldo M Roccaro; Irene M Ghobrial; Michael E O'Dwyer
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

7.  Co-expression of delta-catenin and RhoA is significantly associated with a malignant lung cancer phenotype.

Authors:  Di Zhang; Jun-Yi Zhang; Shun-Dong Dai; Shu-Li Liu; Yang Liu; Na Tang; En-Hua Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

8.  Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.

Authors:  Maoxiao Feng; Xiaochuang Luo; Chunming Gu; Yumin Li; Xuejiao Zhu; Jia Fei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

9.  3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?

Authors:  Pilar de la Puente; Abdel Kareem Azab
Journal:  Future Oncol       Date:  2016-03-30       Impact factor: 3.404

10.  CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2.

Authors:  Manik C Ghosh; Patrudu S Makena; Vijay Gorantla; Scott E Sinclair; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-17       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.